Page last updated: 2024-08-16

ribavirin and Liver Dysfunction

ribavirin has been researched along with Liver Dysfunction in 46 studies

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (6.52)18.2507
2000's28 (60.87)29.6817
2010's13 (28.26)24.3611
2020's2 (4.35)2.80

Authors

AuthorsStudies
Liu, HY; Zhao, JM1
Dourakis, SP; Fragkou, PC; Karofylakis, E; Kavvatha, D; Liatsos, GD; Marantos, T; Pirounaki, M; Sambatakou, H; Sympardi, S; Thomas, K; Tsiodras, S1
Apostu, D; Campian, RS; Ciobanu, L; Ilea, A; Lucaciu, O; Mester, A1
Barbato, A; Cimino, E; Coppola, A; Di Minno, MN; Granata, F; Liccardo, S; Rossi, D; Ruosi, C1
Anthony, DD; Blanton, RE; Judge, CJ; Meng, Q; Phat, S; Rani, MR; Rodriguez, B; Sugalski, JM1
Barin, B; Barnes, D; Curry, M; Dove, L; Johl, J; Millis, M; Peters, M; Poordad, F; Reddy, KR; Regenstein, F; Roland, M; Schiano, T; Schiff, E; Shaikh, O; Shetty, K; Stock, P; Terrault, N1
Asselah, T; Boyer, N; Duval, X; Guedj, J; Kutala, BK; Marcellin, P; Martinot-Peignoux, M; Mouri, F; Valla, D1
Akhtar, M; Gititu, E; Jalluri, C; Ramirez, J; Wilkins, T1
Clark, S; Cooke, GS; Gellissen, R; Irving, W; Main, J; Padam, P; Thomson, E1
Bahirwani, R; Berg, C; Brown, RS; Castells, L; Chacko, KR; Durand, CM; ElSharkawy, AM; Emond, B; Ferenci, P; Fontana, RJ; Herzer, K; Ionescu-Ittu, R; Jafri, SM; Joshi, S; Knop, V; Lionetti, R; Loiacono, L; Londoño, MC; Montalbano, M; Moreno-Zamora, A; Mubarak, A; Pellicelli, AM; Prieto, M; Reddy, KR; Stadler, B; Stauber, RE; Stenmark, S; Torti, C; Vekeman, F; Weiland, O1
Ingiliz, P; Jimenez-Exposito, MJ; Peck-Radosavljevic, M; Petersen, J; Rockstroh, JK; Van der Valk, M; Welzel, TM; Zeuzem, S; Zhao, Y1
Pár, A; Pár, G1
Bailey, KW; Furuta, Y; Gowen, BB; Hall, JO; Jung, KH; Morrey, JD; Smee, DF; Stevens, JR; Wong, MH1
Buck, M; Feldstein, A; Kleiner, D; Kravetz, D1
Abradelo, M; Colina, F; Fernández, I; Gimeno, A; Jiménez, C; Lumbreras, C; Meneu, JC; Moreno, E; Solís-Herruzo, JA; Ulloa, E1
Aghemo, A; Colombo, M; Coppola, A; Mancuso, ME; Mannucci, PM; Puoti, M; Rumi, MG; Santagostino, E1
Badley, AD; Cummins, NW; Klein, MB; Rider, DN; Rizza, SA; Saeed, S1
Bukh, J1
Naggie, S; Sulkowski, MS1
Brjalin, V; Jõeste, E; Lapidus, N; Prikk, K; Salupere, R; Tefanova, V1
Allan, JE; de Boer, WB; Jeffrey, GP; MacQuillan, GC; McCaul, KA; Platten, MA; Reed, WD1
Allan, JE; Jeffrey, GP; MacQuillan, GC; Mamotte, C; Reed, WD1
Bacon, BR1
Chen, XG; Cui, HJ; Duan, J; Gong, YW; Hao, YX; Hua, CJ; Li, AG; Li, P; Tong, XL; Zhang, B; Zhang, ZY; Zhen, M1
Guzman, H; Sbrana, E; Tesh, RB; Travassos da Rosa, AP; Xiao, SY; Ye, M1
González-Peralta, RP1
Ascher, NA; Bollinger, K; Khalili, M; Roberts, JP; Shergill, AK; Straley, S; Terrault, NA1
Cengiz, C; Dieterich, DT; Park, JS; Saraf, N1
Maier, KP1
Dieterich, DT; Park, JS; Saraf, N1
Beckebaum, S; Broelsch, CE; Cicinnati, VR; Gerken, G1
Brok, J; Gluud, C; Gong, Y; Koretz, RL1
Kallman, J; Kincaid, J; Younossi, Z1
Bortolotti, F; Guido, M1
Fiel, MI; Saraf, N; Schiano, TD; Shukla, D; Xu, R1
Basgoz, N; Bica, I; Birch, C; Davis, B; Gandhi, RT; Graeme-Cook, F; McGovern, BH; Quirk, JR; Stone, D; Zachary, K; Zaman, MT1
Adla, M; Ahmad, J; Downey, KK1
Juszczyk, J1
Brinton, MA; Gavin, EI; Lo, WK; Morahan, PS; Pinto, AJ1
Clarysse, C; Suwandhi, W; Verslype, C; Yap, SH1
Clement, RP; Glue, P; Gupta, S; Salfi, M; Schenker, S; Zambas, D1
Mert, A; Ozaras, R; Ozbay, G; Senturk, H; Tabak, F; Tahan, V1
Di Bisceglie, AM1
Donahue, P; Hasan, I; Lebovics, E; Rehman, R; Rigas, B; Wittkowski, KM1
Di Bisceglie, AM; McHutchison, J; Rice, CM1
Koczorek, M1

Reviews

17 review(s) available for ribavirin and Liver Dysfunction

ArticleYear
Clinical features and management of oral lichen planus (OLP) with emphasis on the management of hepatitis C virus (HCV)-related OLP.
    Bosnian journal of basic medical sciences, 2018, Aug-01, Volume: 18, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis C; Humans; Inflammation; Interferon-alpha; Lichen Planus, Oral; Liver Diseases; Male; Middle Aged; Prevalence; Ribavirin

2018
Diagnosis and Management of Hepatitis C.
    American family physician, 2015, Jun-15, Volume: 91, Issue:12

    Topics: Antiviral Agents; Disease Progression; Genotype; Hepacivirus; Hepatitis Antibodies; Hepatitis C; Humans; Interferon-alpha; Liver Diseases; Mass Screening; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; RNA, Viral; Severity of Illness Index; Viral Load; Viral Nonstructural Proteins

2015
Animal models for the study of hepatitis C virus infection and related liver disease.
    Gastroenterology, 2012, Volume: 142, Issue:6

    Topics: Animals; Antibodies, Neutralizing; Antiviral Agents; Carcinoma, Hepatocellular; Cercopithecidae; Disease Models, Animal; Disease Susceptibility; Hepatitis Antibodies; Hepatitis C; Humans; Immunity, Innate; Interferon-alpha; Liver Diseases; Liver Neoplasms; Mice; Mice, SCID; Pan troglodytes; Platyrrhini; Ribavirin; Virus Replication

2012
Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.
    Gastroenterology, 2012, Volume: 142, Issue:6

    Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Coinfection; Deoxycytidine; Dideoxynucleosides; Disease Progression; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Emtricitabine; Hepatitis C, Chronic; HIV Infections; Homosexuality, Male; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Diseases; Male; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Pyrrolidinones; Raltegravir Potassium; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Substance Abuse, Intravenous; Tenofovir; Treatment Outcome

2012
Managing hepatitis C.
    The American journal of managed care, 2004, Volume: 10, Issue:2 Suppl

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Liver Neoplasms; Polyethylene Glycols; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; United States

2004
HIV and liver diseases: recent clinical advances.
    Clinics in liver disease, 2005, Volume: 9, Issue:4

    Topics: Anti-HIV Agents; Antiviral Agents; Hepatitis C; HIV Infections; Humans; Interferons; Liver; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Ribavirin

2005
[Drug therapy in chronic liver disease].
    Praxis, 2005, Nov-30, Volume: 94, Issue:48

    Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Sclerosing; Chronic Disease; Drug Therapy, Combination; Fatty Liver; Hemochromatosis; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Autoimmune; Hepatolenticular Degeneration; Humans; Immunosuppression Therapy; Interferons; Lamivudine; Liver Cirrhosis, Biliary; Liver Diseases; Organophosphonates; Prednisolone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ribavirin; Time Factors

2005
HBV plus HCV, HCV plus HIV, HBV plus HIV.
    Current gastroenterology reports, 2006, Volume: 8, Issue:1

    Topics: Algorithms; Antiviral Agents; Carcinoma, Hepatocellular; Chronic Disease; Disease Progression; Drug Interactions; Hepatitis B; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load

2006
[Recurrent disease after liver transplantation. A therapeutic dilemma or treatable?].
    Medizinische Klinik (Munich, Germany : 1983), 2006, Dec-15, Volume: 101, Issue:12

    Topics: Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; Cholestasis, Intrahepatic; Disease-Free Survival; Follow-Up Studies; Hepatitis B; Hepatitis C; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Incidence; Interferon-alpha; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Liver Transplantation; Middle Aged; Patient Compliance; Prognosis; Recurrence; Ribavirin; Risk Factors; Time Factors

2006
Hepatology may have problems with putative surrogate outcome measures.
    Journal of hepatology, 2007, Volume: 46, Issue:4

    Topics: Antiviral Agents; Bilirubin; Biomarkers; Cholagogues and Choleretics; Gastroenterology; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferons; Liver Cirrhosis, Biliary; Liver Diseases; Outcome Assessment, Health Care; Reproducibility of Results; Ribavirin; Ursodeoxycholic Acid; Viral Load

2007
The effects of HCV infection and management on health-related quality of life.
    Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:3

    Topics: Antiviral Agents; Chronic Disease; Depression; Fatigue; Health Status; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin

2007
Reversal of liver cirrhosis: a desirable clinical outcome and its pathogenic background.
    Journal of pediatric gastroenterology and nutrition, 2007, Volume: 44, Issue:4

    Topics: Anti-Inflammatory Agents; Antiviral Agents; Biopsy; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Liver Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2007
Hepatic sarcoidosis associated with pegylated interferon alfa therapy for chronic hepatitis C: case report and review of literature.
    Digestive diseases and sciences, 2008, Volume: 53, Issue:10

    Topics: Adult; Antiviral Agents; Biopsy; Chemical and Drug Induced Liver Injury; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Diseases; Male; Peptidyl-Dipeptidase A; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sarcoidosis

2008
[Advances in the research of viral hepatitis].
    Przeglad epidemiologiczny, 1994, Volume: 48, Issue:4

    Topics: Hepatovirus; Humans; Interferons; Liver Diseases; Research; Ribavirin

1994
Hepatitis C: seven years after the discovery of the causative agent.
    Acta clinica Belgica, 1997, Volume: 52, Issue:1

    Topics: Antiviral Agents; Genome, Viral; Genotype; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Diseases; Ribavirin; RNA, Viral

1997
Hepatic granulomas in chronic hepatitis C.
    Journal of clinical gastroenterology, 2001, Volume: 33, Issue:4

    Topics: Biopsy, Needle; Drug Therapy, Combination; Female; Follow-Up Studies; Granuloma; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Liver Diseases; Liver Function Tests; Middle Aged; Ribavirin; Risk Assessment; Treatment Outcome

2001
New therapeutic strategies for hepatitis C.
    Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:1

    Topics: Animals; Antiviral Agents; Cell Culture Techniques; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Hepacivirus; Hepatitis C; Humans; IMP Dehydrogenase; Interferons; Liver Diseases; Ribavirin; Virus Replication

2002

Trials

2 trial(s) available for ribavirin and Liver Dysfunction

ArticleYear
Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy.
    Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:12

    Topics: Adult; Female; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferons; Liver Diseases; Male; Polyethylene Glycols; Ribavirin; Treatment Outcome

2009
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:1

    Topics: Adult; Aged; Antiviral Agents; Biopsy; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Growth Substances; Hepatitis C; Humans; Immunocompromised Host; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Interferons; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Polyethylene Glycols; Prednisone; Recombinant Proteins; Ribavirin; Tacrolimus; Time Factors

2005

Other Studies

27 other study(ies) available for ribavirin and Liver Dysfunction

ArticleYear
[Intrahepatic and extrahepatic clinical manifestations and treatment progress for hepatitis type E].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023, May-20, Volume: 31, Issue:5

    Topics: Antiviral Agents; Hepatitis E virus; Hepatitis, Chronic; Humans; Liver Diseases; Liver Failure; Ribavirin

2023
Clinical characteristics and outcomes of measles outbreak in adults: A multicenter retrospective observational study of 93 hospitalized adults in Greece.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2020, Volume: 131

    Topics: Abortion, Spontaneous; Adolescent; Adult; Antiviral Agents; Female; Greece; Hospitalization; Humans; Liver Diseases; Male; Measles; Measles virus; Middle Aged; Pneumonia; Pregnancy; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome; Vaccination; Young Adult

2020
Our experience about the particular surgical management of total hip replacement in two patients with severe haemophilic arthropathy: case report.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2013, Volume: 19, Issue:3

    Topics: Antiviral Agents; Arthropathy, Neurogenic; Arthroplasty, Replacement, Hip; Drug Therapy, Combination; Hemophilia A; Hepatitis C; Hip; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Male; Middle Aged; Polyethylene Glycols; Radiography; Recombinant Proteins; Ribavirin; Severity of Illness Index

2013
Natural cytotoxicity receptor-dependent natural killer cytolytic activity directed at hepatitis C Virus (HCV) is associated with liver inflammation, African American race, IL28B genotype, and response to pegylated interferon/ribavirin therapy in chronic H
    The Journal of infectious diseases, 2014, May-15, Volume: 209, Issue:10

    Topics: Adult; Antiviral Agents; Black or African American; Female; Gene Expression Regulation; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Killer Cells, Natural; Liver Diseases; Lysosomal-Associated Membrane Protein 1; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2014
Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2014, Volume: 14, Issue:5

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Liver Diseases; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Prognosis; Prospective Studies; Recombinant Proteins; Ribavirin; Survival Rate; Transplant Recipients; Treatment Outcome; Young Adult

2014
Impact of treatment against hepatitis C virus on overall survival of naive patients with advanced liver disease.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:2

    Topics: Adult; Antiviral Agents; Female; Hepacivirus; Humans; Interferons; Liver Diseases; Male; Middle Aged; Prospective Studies; Ribavirin

2015
Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver disease.
    Journal of viral hepatitis, 2016, Volume: 23, Issue:2

    Topics: Adult; Antiviral Agents; Cohort Studies; Coinfection; Delivery of Health Care; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Liver Diseases; Male; Middle Aged; Patient Acceptance of Health Care; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Viral Load

2016
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2016, Volume: 22, Issue:4

    Topics: Aged; Antiviral Agents; Carbamates; Compassionate Use Trials; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Treatment Outcome; Valine

2016
Daclatasvir plus sofosbuvir, with or without ribavirin, in real-world patients with HIV-HCV coinfection and advanced liver disease.
    Antiviral therapy, 2017, Volume: 22, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Imidazoles; Liver Diseases; Liver Function Tests; Male; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Treatment Outcome; Valine; Viral Load

2017
[The 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), Milan, Italy, April 23-27, 2008].
    Orvosi hetilap, 2008, Jul-13, Volume: 149, Issue:28

    Topics: Antineoplastic Agents; Antiviral Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Clinical Trials as Topic; Delayed-Action Preparations; Europe; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Liver Neoplasms; Niacinamide; Oligopeptides; Patient Compliance; Phenylurea Compounds; Polyethylene Glycols; Proline; Pyridines; Recombinant Proteins; Ribavirin; Societies, Medical; Sorafenib

2008
Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin.
    PloS one, 2008, Volume: 3, Issue:11

    Topics: Absorption; Administration, Oral; Alanine Transaminase; Amides; Animals; Arenaviridae Infections; Aspartate Aminotransferases; Cricetinae; Disease Models, Animal; Disease Progression; Female; Hemorrhagic Fevers, Viral; Interferon Type I; Liver Diseases; Mesocricetus; Pichinde virus; Pyrazines; Ribavirin; Survival Analysis; Treatment Outcome; Viral Load

2008
Severe hepatocellular injury with apoptosis induced by a hepatitis C polymerase inhibitor.
    Journal of clinical gastroenterology, 2009, Volume: 43, Issue:4

    Topics: Antiviral Agents; Apoptosis; Benzofurans; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Interferons; Liver; Liver Diseases; Male; Middle Aged; Polyethylene Glycols; Ribavirin; Sulfonamides

2009
Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2009, Volume: 15, Issue:8

    Topics: Adult; Aged; Antiviral Agents; Cyclosporine; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Interferons; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Ribavirin; Risk Factors; Treatment Outcome

2009
Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals.
    AIDS (London, England), 2010, Nov-13, Volume: 24, Issue:17

    Topics: Adult; Antiviral Agents; Canada; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Male; Middle Aged; Polymorphism, Genetic; Receptors, Tumor Necrosis Factor, Member 25; Recombinant Proteins; Ribavirin; RNA, Viral

2010
Sarcoidosis and chronic hepatitis C: a case report.
    World journal of gastroenterology, 2012, Oct-28, Volume: 18, Issue:40

    Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Biopsy; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Diseases; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sarcoidosis; Sarcoidosis, Pulmonary; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2012
Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection.
    Journal of medical virology, 2002, Volume: 68, Issue:2

    Topics: Adult; Antiviral Agents; Case-Control Studies; Cohort Studies; eIF-2 Kinase; GTP-Binding Proteins; Hepatitis C, Chronic; Humans; Immunohistochemistry; Interferon alpha-2; Interferon-alpha; Liver; Liver Diseases; Myxovirus Resistance Proteins; Proteins; Recombinant Proteins; Ribavirin

2002
Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection.
    Journal of medical virology, 2003, Volume: 70, Issue:2

    Topics: 2',5'-Oligoadenylate Synthetase; Adult; Cytokines; Drug Therapy, Combination; eIF-2 Kinase; Female; GTP-Binding Proteins; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukin-8; Liver; Liver Diseases; Male; Myxovirus Resistance Proteins; Proteins; Recombinant Proteins; Ribavirin; RNA, Messenger; Ubiquitins; Up-Regulation

2003
Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: retrospective analysis.
    World journal of gastroenterology, 2004, Jun-01, Volume: 10, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Child; Female; Humans; Incidence; L-Lactate Dehydrogenase; Liver; Liver Diseases; Liver Function Tests; Male; Middle Aged; Retrospective Studies; Ribavirin; Severe Acute Respiratory Syndrome

2004
Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease.
    The American journal of tropical medicine and hygiene, 2004, Volume: 71, Issue:3

    Topics: Animals; Antiviral Agents; Cricetinae; Female; Liver Diseases; Mesocricetus; Models, Animal; Ribavirin; Treatment Outcome; Yellow Fever

2004
Treatment of chronic hepatitis C in children.
    Pediatric transplantation, 2004, Volume: 8, Issue:6

    Topics: Antiviral Agents; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral

2004
Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Biopsy; Female; Granuloma; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Sarcoidosis

2008
Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Nov-15, Volume: 45, Issue:10

    Topics: Anti-HIV Agents; Antiviral Agents; Biopsy; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Female; Hepatitis C; HIV; HIV Infections; Humans; Interferons; Liver; Liver Cirrhosis; Liver Diseases; Male; Necrosis; Ribavirin; RNA, Viral; Transaminases; Viral Load

2007
Characterization of murine Caraparu Bunyavirus liver infection and immunomodulator-mediated antiviral protection.
    Antiviral research, 1993, Volume: 20, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Antiviral Agents; Bunyaviridae Infections; Female; Interferon-gamma; Liver; Liver Diseases; Mice; Mice, Inbred Strains; Microscopy, Electron; Orthobunyavirus; Recombinant Proteins; Ribavirin; Virus Replication

1993
The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease.
    British journal of clinical pharmacology, 2000, Volume: 49, Issue:5

    Topics: Adult; Chronic Disease; Female; Humans; Liver Diseases; Male; Middle Aged; Ribavirin

2000
SEN and sensibility: interactions between newly discovered and other hepatitis viruses?
    Lancet (London, England), 2001, Dec-08, Volume: 358, Issue:9297

    Topics: Antiviral Agents; DNA Virus Infections; DNA Viruses; Hepatitis C, Chronic; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Recombinant Proteins; Ribavirin; Treatment Outcome

2001
Effect on treatment outcome of coinfection with SEN viruses in patients with hepatitis C.
    Lancet (London, England), 2001, Dec-08, Volume: 358, Issue:9297

    Topics: Alanine Transaminase; Antiviral Agents; DNA Primers; DNA Virus Infections; DNA Viruses; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Male; Polymerase Chain Reaction; Recombinant Proteins; Ribavirin; RNA, Viral; Sequence Analysis, DNA; Treatment Outcome

2001
[Chronic liver diseases. The nihilism has gone].
    MMW Fortschritte der Medizin, 2001, Dec-13, Volume: 143, Issue:51-52

    Topics: Amantadine; Antioxidants; Antiviral Agents; Chronic Disease; Dipeptides; Drug Therapy, Combination; Flumazenil; GABA Modulators; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Diseases; Pentoxifylline; Phosphodiesterase Inhibitors; Prospective Studies; Protective Agents; Ribavirin; Silymarin

2001